ETFs › IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA)

healthcare biotechnology genomics

IDNA provides targeted exposure to companies at the intersection of healthcare and cutting-edge technology. It focuses on firms involved in genomics, immunology, and bioengineering. This ETF offers a way to invest in potential breakthroughs in personalized medicine and next-generation healthcare solutions.

Key Info

AUM $230M
Expense Ratio 0.47%
Inception Date June 11, 2019
Distribution Frequency Annually
Weighting Method Modified Market Cap
Number of Holdings 47
Tracking Index NYSE FactSet Global Genomics and Immuno Biopharma Index

See Also

ARKG XBI BBH

Last updated: September 7, 2024